- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 1
This study is testing a new medicine, ALKS 2680, for people with Narcolepsy Type 1. It aims to see how safe the medicine is and how well different doses work to help with symptoms like extreme sleepiness.
For: Narcolepsy Type 1Czechia · Italy · France - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 2
This study is looking into a new medication called ALKS 2680 for people with Narcolepsy Type 2. We want to see if it's safe and helps improve sleepiness. Some people will get the new medicine, and others a dummy pill, to compare the results.
For: Narcolepsy Type 2Spain · Czechia · France